Solid tumors
Conditions
Interventions
Co-ablation group:None
Sponsors
Sun Yat-sen University Cancer Center
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1) Patients who have completed/planned Ablation using Co-ablation system; 2) Age range: 18-75 years old; 3) Diagnosed and treated with ablation therapy for one of the following types of tumors: 1. Liver tumors; 2. Breast tumors; 3. Lung tumors; 4. Tumors of the urinary and reproductive system; 4. pancreatic cancer; 5. Bone and soft tissue tumors 4) ECOG PS score 0-1 points before ablation.
Exclusion criteria
Exclusion criteria: 1) do not plann to undergo Co-ablation of solid tumors 2) Child Pugh score = 7 points; Decompensated liver function, such as the appearance of large amounts of ascites, gastric varices, and upper gastrointestinal bleeding within one year; hepatic encephalopathy; bilirubin encephalopathy. 3) Known and instable status of central nervous system metastasis, or acute meningitis; 4) Suffer from severe liver and kidney function damage, or uncontrollable diabetes, pulmonary fibrosis, interstitial lung disease, acute lung disease, or hypertension with poor drug control (systolic pressure>160mmHg and/or diastolic pressure>90mmHg), or clinically significant (such as active) cardiovascular and cerebrovascular diseases, such as cerebrovascular accident within 6 months, myocardial infarction, unstable angina, congestive heart failure with NYHA grade II or above, serious arrhythmia can not be controlled by drugs, and ECG results show clinically significant differences in 3 consecutive times (at least 5 minutes between each time); Any situation that researchers believe may increase the risk to subjects or interfere with the test results, whether it is due to mental illness or drug abuse; 5) Patients with other serious acute or chronic physiological or mental illnesses or abnormal laboratory tests may increase the risk of research or interfere with the interpretation of results, making them unsuitable for inclusion.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Efficacy;Safety; | — |
Secondary
| Measure | Time frame |
|---|---|
| Overall survival;Progression-free survival;LeTime for the ablative procedure;Applicability; | — |
Countries
China
Contacts
Public ContactWeijun Fan
Sun Yat-sen University Cancer Center
Outcome results
None listed